Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Immediate short implants to replace a single extracted tooth

Official title: Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites: a Randomized Controlled Trial.

Run by University of Bari Aldo Moro · NCT07177521 · Data updated 2026-11-12

This study will test whether placing short dental implants right after removing a single tooth in patients with limited bone provides solid support and healthy gum and bone healing.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment10 (estimated)
SponsorUniversity of Bari Aldo Moro
Academic / other
Locations1 site (Bari)
StatusRecruiting
StartedJanuary 10, 2025
Main results expectedJune 1, 2026
Study endsAugust 10, 2026
Registry record updatedJanuary 27, 2026
Trial IDNCT07177521 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) needing immediate single-tooth replacement in posterior sites or selected anterior sites, with good oral hygiene and a planned short implant (≤7–8 mm), are ideal candidates.

Probably not a fit

Patients who are heavy smokers (>20 cigarettes/day), have uncontrolled diabetes or conditions that impair bone healing, are on antiresorptive therapy, are immunosuppressed or pregnant, have poor oral hygiene or acute site infection, or have severe bone dehiscence are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants who need a single-tooth replacement following extraction (primarily premolars and molars, and some selected anterior sites) will receive a short implant (about 7–8 mm or shorter) placed immediately into the extraction socket. The trial will focus on how the peri-implant gap and soft-tissue management affect primary implant stability and subsequent hard- and soft-tissue remodeling. Clinical measurements and radiographs will be used during follow-up visits to monitor stability, tissue changes, and implant survival. Patients with significant bone defects or contraindications to healing will be excluded to preserve primary stability and standardize results.

Why it matters

Potential benefit: If successful, this approach could offer a faster, less invasive option for replacing a single tooth when vertical bone height is limited.

How similar studies have gone: Previous clinical reports on immediate placement and on short implants have shown promising results in well-selected patients, though outcomes depend strongly on case selection and soft-tissue/bone management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Single-tooth post-extraction sites requiring immediate implant placement in posterior regions (premolars/molars) or selected anterior sites.
* Planned short implant (≤7-8 mm length, 3.5-5.0 mm diameter).
* Adequate oral hygiene, no active periodontal disease.
* Written informed consent.

Exclusion Criteria:

* Heavy smoking (\>20 cigarettes/day).

  * Uncontrolled diabetes or systemic conditions affecting bone healing.
  * Current bisphosphonate/antiresorptive therapy.
  * Immunosuppression, pregnancy.
  * Poor oral hygiene or acute infection at site.
  * Severe bone dehiscence preventing primary stability.

Where it's running

  • University of Bari Aldo Moro
    Bari, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.